Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.580
-0.010 (-0.22%)
Apr 3, 2025, 4:08 PM HKT

HKG:9989 Revenue

In the year 2024, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.26B CNY, down -3.43%. Shenzhen Hepalink Pharmaceutical Group had revenue of 1.19B in the quarter ending December 31, 2024, a decrease of -13.91%.

Revenue
5.26B CNY
Revenue Growth
-3.43%
P/S Ratio
n/a
Revenue / Employee
2.53M CNY
Employees
2,080
Market Cap
16.39B HKD

Revenue Chart

* This company reports financials in CNY.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.26B-186.65M-3.43%
Dec 31, 20235.45B-1.71B-23.94%
Jan 1, 20237.16B794.23M12.48%
Jan 1, 20226.37B1.03B19.38%
Dec 31, 20205.33B707.42M15.30%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition